Instituto de Investigación Sanitaria Hospital Clínico San Carlos

What Instituto de Investigación Sanitaria Hospital Clínico San Carlos does

IdISSC is a public, non-profit Health Research Institute accredited by the Instituto de Salud Carlos III (ISCIII) on 23 March 2011 and physically embedded within Hospital Clínico San Carlos in Madrid. It is a multi-institutional translational research platform that coordinates more than 50 research groups across six scientific areas — Cardiovascular; Inflammation, Infection, Immunity and Allergy; Neuroscience; Oncology; Other Large Systems; and Advanced Technologies and Model Translation. The institute is jointly governed by SERMAS, Hospital Clínico San Carlos, Universidad Complutense de Madrid (UCM), Universidad Politécnica de Madrid (UPM), the FIBHCSC foundation, and the Department of Health of the Community of Madrid, and serves a mixed user base of hospital clinicians, university researchers, primary-care professionals and, via its Innovation Unit, biotech and ICT companies.

The institute's core "product" is its research infrastructure rather than commercial goods. It operates more than 25 transversal research support units, including a Biobank, Flow Cytometry Unit, Cell Therapy Clean Room, Experimental Therapies Unit, Genomics Unit, Microbiota Laboratory (LABMIC), animal facility/UMECE, Methodological Support (UAMI), Clinical Trials (UICEC), Phase I Clinical Pharmacology (UFARCLI), Innovation Support, and Patient Experience in Research (UEXPI). It also runs an Innovation Unit branded as Smart Health, which houses Smart Health LAB (a mobile-health/ICT development lab) and the registered-trademark Ideas Incubator, a monthly thematic ecosystem platform connecting clinicians, companies and other institutions. HRS4R and DORA/CoARA-aligned research-evaluation frameworks, an annual training plan, a mentorship plan, and a Strategic Plan 2026-2030 complete the institutional product layer.

The business model is a public-sector research funding model, not a commercial SaaS or product model. IdISSC does not publicly disclose commercial pricing; service fees are administered through a Transparency Portal. Revenue is generated through competitive public research grants (ISCIII, EU, national/regional), institutional allocations from SERMAS and the Community of Madrid, clinical trial management fees, technology-transfer and innovation partnerships with industry (via Smart Health), and donations processed through the FIBHCSC foundation. The primary customer segments are internal (researchers and clinicians at HCSC, UCM and UPM) and institutional (SERMAS, Community of Madrid), with biotech/ICT firms as a secondary collaborator segment.

Name

Instituto de Investigación Sanitaria Hospital Clínico San Carlos

Legal name

Fundación para la Investigación Biomédica del Hospital Clínico San Carlos

Website

https://idissc.org

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

IdISSC is a public, ISCIII-accredited translational biomedical research institute based in Hospital Clínico San Carlos, Madrid, coordinating 50+ research groups and 25+ support units across six scientific areas for clinicians, university researchers, and the Madrid health system.

Ownership category

akta.pro rank

Product category

Translational Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Professional, Scientific, and Technical Services (54)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Clinical Trial Pharmacy & IMP Management at Site (HLAGACAK)

akta.pro secondary industry

Clinical Operations & Monitoring FSP (CRA/CTM/Start-up) (HLAGAOAA)

Keywords

• Translational biomedical research
• Clinical research support
• Health innovation transfer
• Biomedical research infrastructure
• Clinical trials coordination

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Others

Distribution channels3 records

Marketing channels8 records

Core offering

The IdISSC is a public health research institute that delivers translational biomedical research across six scientific areas, supported by more than 20 transversal research support units and an Innovation Unit (Smart Health) that develops mobile health technologies and operates the Ideas Incubator. It provides clinical trial coordination, methodological support, biobank services, and training/mentorship programs to affiliated researchers, hospital clinicians, and collaborating public and private health-sector organizations, acting as the institutional platform for transferring research results to clinical practice.

Product overview

IdISSC is a Health Research Institute that functions as a research platform rather than a product company. It offers a portfolio of 6 research areas (Cardiovascular, Inflammation/Infection/Immunity/Allergy, Neuroscience, Oncology, Other Large Systems, and Advanced Technologies/Model Translation), 25+ transversal research support units (including Biobank, Flow Cytometry, Experimental Therapies, Clinical Trials, Clean Room, and Genomics), an Innovation Unit branded as Smart Health (with Smart Health LAB for mobile health and Ideas Incubator), plus training services including research seminars, mentorship programs, and doctoral thesis defense. The institute coordinates research between Hospital Clínico San Carlos, Complutense University of Madrid, and Polytechnic University of Madrid.

Differentiator

Problem solved

Functional benefit

Brands

• Smart Health: Brand of the Innovation Unit focused on innovative solutions with technological support for the health sector, including Smart Health LAB for mobile health technologies.
• Smart Health LAB
• Ideas Incubator

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Instituto de Salud Carlos III - ITEMAS NetworkcoreStrategic or Co-development Partner · 1 January 2010The IdISSC's Innovation Unit originated from participation in the ITEMAS Network created by the Instituto de Salud Carlos III in 2010, a national network promoting healthcare innovation and fostering collaboration between healthcare companies and medical professionals to develop new technologies for patient care.
• Hospital Clínico San Carlos (HCSC)coreStrategic or Co-development PartnerThe Hospital Clínico San Carlos is a founding institutional member of the IdISSC. The institute is physically located within the hospital complex (C/ Profesor Martín Lagos, s/n, 28040 Madrid) and serves as the primary clinical research environment for translational biomedical research. The hospital provides clinical infrastructure, patient access, and clinical personnel for the institute's research programmes.
• Universidad Complutense de Madrid (UCM)coreStrategic or Co-development PartnerThe Complutense University of Madrid is a founding institutional member of the IdISSC, providing academic researchers, doctoral programmes, and access to university research facilities. The institute facilitates collaboration between university researchers and hospital clinicians, including mixed research groups and joint projects.
• Universidad Politécnica de Madrid (UPM)coreStrategic or Co-development PartnerThe Polytechnic University of Madrid is a founding institutional member of the IdISSC, contributing engineering and technology expertise to the institute's research and innovation activities, particularly in the Advanced Technologies and Model Translation research area.
• Fundación para la Investigación Biomédica del Hospital Clínico San Carlos (FIBHCSC)coreStrategic or Co-development PartnerThe FIBHCSC is the biomedical research foundation and management entity of the IdISSC. It handles the institute's financial management, project administration, human resources, donations, and legal affairs. It acts as the organizational backbone for the institute's operations.
• Comunidad de Madrid - Servicio Madrileño de Salud (SERMAS)coreStrategic or Co-development PartnerThe Madrid Health Service (SERMAS) and the Department of Health (Dirección General de Investigación, Formación y Documentación) of the Community of Madrid are founding institutional members, providing healthcare system integration, primary health care centre access, and public health governance.
• Biotechnology and ICT companies (via Ideas Incubator)minorGTM or Marketing PartnerThe Ideas Incubator serves as a platform for convergence of different profiles including hospital staff, companies in the health sector, institutions, and other hospital centres. It brings together knowledge from healthcare, research, technology, communication, and industry through monthly thematic sessions, creating an ecosystem for health innovation and entrepreneurship.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Vall d'Hebron Institut d'Oncologia (VHIO): VHIO is a Barcelona-based oncology-focused translational research institute accredited by ISCIII and integrated within Vall d'Hebron University Hospital. Comparable as a Spanish ISCIII-accredited translational research institute co-located with a large tertiary hospital, with multi-area research groups, clinical trial units, and industry partnership models.
• Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM): IiSGM is a Madrid-based ISCIII-accredited health research institute integrated with Hospital General Universitario Gregorio Marañón. Most directly comparable peer — same city, same accreditation framework, same hospital-integrated translational model, and similar multi-area research structure (cardiovascular, oncology, neuroscience, infectious diseases).
• Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS): IDIBAPS is a Barcelona-based ISCIII-accredited translational research institute linked to Hospital Clínic de Barcelona and the University of Barcelona. Closely comparable in structure, scope, and accreditation — multi-area biomedical research integrated with a major university hospital, with strong clinical trials and innovation capacity.
• Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD): IIS-FJD is a Madrid-based ISCIII-accredited research institute integrated with Hospital Universitario Fundación Jiménez Díaz and linked to Universidad Autónoma de Madrid. Comparable as a Madrid-based ISCIII-accredited translational research institute with university-hospital integration and similar research area structure.
• Instituto de Biomedicina de Sevilla (IBIS): IBIS is a Seville-based ISCIII-accredited biomedical research institute linked to Hospital Universitario Virgen del Rocío, Universidad de Sevilla, and CSIC. Comparable Spanish ISCIII-accredited translational research institute with similar multi-area structure and hospital-university-public system integration.
• Instituto de Investigación Sanitaria La Fe (IIS La Fe): IIS La Fe is a Valencia-based ISCIII-accredited research institute integrated with Hospital Universitari i Politècnic La Fe. Comparable ISCIII-accredited translational research institute with similar hospital integration, multi-area research structure, and clinical trials infrastructure.
• Centro de Investigación Médica Aplicada (CIMA) - Universidad de Navarra: CIMA is a Pamplona-based translational biomedical research center linked to Clínica Universidad de Navarra and Universidad de Navarra. Comparable Spanish translational biomedical research institute with hospital-university integration, multi-area research, and clinical trial infrastructure.
• Fundación Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS): IDIS is a Santiago de Compostela-based ISCIII-accredited health research institute integrated with Hospital Clínico Universitario de Santiago and Universidad de Santiago de Compostela. Comparable Spanish ISCIII-accredited translational research institute with similar multi-area research structure and hospital-university integration model.

Broad incumbents

• Centro Nacional de Investigaciones Oncológicas (CNIO): CNIO is a large Spanish national cancer research center with a broader national scope and deeper oncology specialization than IdISSC. Comparable as a leading Spanish biomedical research entity but with national rather than regional scope, and single-disease focus versus IdISSC's multi-area model.

Regional players

• Institut de Recerca Biomèdica de Lleida (IRBLleida): IRBLleida is a Catalonia-based ISCIII-accredited biomedical research institute integrated with Hospital Universitari Arnau de Vilanova. Comparable ISCIII-accredited translational research institute with hospital-university integration, but serving the Lleida regional catchment rather than Madrid.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/iis_idissc
• Facebookfacebook.com/IdISSC
• LinkedInlinkedin.com/company/idissc

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto de Investigación Sanitaria Hospital Clínico San Carlos